![胰岛素抵抗糖尿病与冠心病(英文)_第1页](http://file4.renrendoc.com/view/ac6fe1a39e207aaf308a4965879a8d37/ac6fe1a39e207aaf308a4965879a8d371.gif)
![胰岛素抵抗糖尿病与冠心病(英文)_第2页](http://file4.renrendoc.com/view/ac6fe1a39e207aaf308a4965879a8d37/ac6fe1a39e207aaf308a4965879a8d372.gif)
![胰岛素抵抗糖尿病与冠心病(英文)_第3页](http://file4.renrendoc.com/view/ac6fe1a39e207aaf308a4965879a8d37/ac6fe1a39e207aaf308a4965879a8d373.gif)
![胰岛素抵抗糖尿病与冠心病(英文)_第4页](http://file4.renrendoc.com/view/ac6fe1a39e207aaf308a4965879a8d37/ac6fe1a39e207aaf308a4965879a8d374.gif)
![胰岛素抵抗糖尿病与冠心病(英文)_第5页](http://file4.renrendoc.com/view/ac6fe1a39e207aaf308a4965879a8d37/ac6fe1a39e207aaf308a4965879a8d375.gif)
版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
EpidemiologyofInsulinResistance,DiabetesMellitus,andCoronaryHeartDisease
StevenHaffner,MDAdaptedfromWorldHealthOrganization.Definition,DiagnosisandClassificationofDiabetesMellitus
anditsComplications.Geneva:WorldHealthOrganization:1999:52.CriteriafortheDiagnosisofDiabetesMellitusandHyperglycemia
PlasmaGlucoseConcentration>7.0(>126)
>6.1(>110)to<7.0(<126)2-HourPost
GlucoseLoadFasting
GlucoseDiabetesMellitusImpairedGlucoseToleranceImpairedFastingGlucose>11.1(>200)>7.8(>140)to
<11.1(<200)
Valuesaremmol/L(mg/dl)DevelopedDevelopingPercentKingHetal.DiabetesCare1998;21:1414-1431.World1995PrevalenceofDiabetesinAdultPopulation
(Aged>20years)byYearandRegion20002025HospitalizationCostsforChronicComplicationsofDiabetesintheUSAmericanDiabetesAssociation.EconomicConsequencesofDiabetesMellitus
intheUSin1997.Alexandria,VA:AmericanDiabetesAssociation,1998:1-14.Totalcosts12billionUS$CVDaccountsfor64%oftotalcostsOthersOphthalmic
diseaseCardiovascular
diseaseRenal
diseaseNeurologic
diseasePeripheral
vascular
diseaseAnnualCHDDeathsper1000PersonsKannelWB,McGeeDL.JAMA1979;241:2035-2038.FraminghamStudy:DMandCHDMortality
20-YearFollow-up178174MenWomenDMNon-DMIschemic
heart
disease%ofDeathsGeissLSetal.In:DiabetesinAmerica.2nded.1995;chap11.MortalityinPeoplewithDiabetes
CausesofDeathOther
heart
diseaseDiabetesCancerStrokeInfectionOtherMortalityper1000
person-years**Age-adjustedAdaptedfromGuKetal.DiabetesCare1998;21:1138-1145.MortalityDuetoHeartDiseaseinMenandWomenwithorwithoutDiabetes(US)29.919.2MenWomenDiabetesNoDiabetesAllheartdiseaseIschemicheartdiseaseMenWomen11.56.323.07.111.03.6NondiabetesDiabetes*Definedin1971-1975,followedupthrough1982-1984.
**Definedin1982-1984,followedupthrough1992-1993.GuKetal.JAMA1999;281:1291-1297.TrendsinMortalityRatesforIschemicHeartDiseaseinNHANESSubjectswithandwithoutDiabetes*17.06.8-16.6%+10.7%Men,cohort1*Men,cohort2**Women,cohort1*Women,cohort2**-43.8%-20.4%14.27.67.44.22.41.9(P=0.46)(P=0.76)(P<0.001)(P=0.12)Rateper1000person-yearsWOMENMENSurvivalPost-MIinDiabeticandNondiabeticMenandWomen:MinnesotaHeartSurveyAdaptedfromSprafkaJMetal.DiabetesCare1991;14:537-543.1008060400Survival(%)MonthsPost-MINodiabetesn=228n=1628MonthsPost-MISurvival(%)0204060Diabetes100806040080020406080DiabetesNodiabetesn=156n=568WOMENMENCardiovascularMortalityinPeople
withDiabetes%ofDeaths(CrudeRate)AdaptedfromMiettinenHetal.DiabetesCare.1998;21:69-75.DiabetesNoDiabetes28.622.110.911.9DiabetesNoDiabetes15.49.622.79.09.14.211.12.828d–1yHospitalization–28dOutofHospitalInfluenceofMultipleRiskFactors*onCVDDeathRatesinDiabeticandNondiabeticMen:MRFITScreeneesNoneOneonlyAge-adjustedCVDdeathrateper10,000person-years*Serumcholesterol>200mg/dl,smoking,SBP>120mmHgStamlerJetal.DiabetesCare1993;16:434-444AllthreeNodiabetesDiabetesTwoonlyPutativeMechanismforIncreasedAtherosclerosisinType2DiabetesBLACKBOXDyslipidemiaHypertensionHyperinsulinemia/insulinresistanceHemostaticabnormalitiesHyperglycemiaAGEproteinsOxidativestressAGE=advancedglycationendproductsAdaptedfromBiermanEL.Arterioscler
Thromb1992;12:647-656.+=moderatelyincreasedcomparedwithnondiabeticpopulation++=markedlyincreasedcomparedwithnondiabeticpopulation–=notdifferentcomparedwithnondiabeticpopulationPrevalenceofCardiovascularRiskFactorsinDiabeticSubjectsRelativetoNondiabeticsType1Dyslipidemia
Hypertriglyceridemia
LowHDL
Small,denseLDL
IncreasedapoBHypertensionHyperinsulinemia/insulinresistanceCentralobesityFamilyhistoryofatherosclerosisCigarettesmokingAdaptedfromChaitA,BiermanEL.In:Joslin’sDiabetesMellitus.Philadelphia:Lea&Febiger,1994:648-664.Type2RiskFactor
+–––+––––
+++++++++++++++–DifferencesinHDLCholesterolandLDLSizebyDiabeticStatusinWomenandMenHowardBVetal.DiabetesCare1998;21:1258-1265.0-2-4-6-8DifferencesbetweenparticipantswithandwithoutdiabetesHDLCholesterolLDLSizeÅ0-2-4-6-8mg/dLWomenMenWomenMenStrategiesforReductionofDiabeticComplicationsMicrovascularcomplications
-Aggressivescreening
-ImprovedmetaboliccontrolMacrovascularcomplications
-Improvedglycemiccontrol(positivebutminor)
-Preventionoftype2diabetes
-AggressivetreatmentofestablishedCVRFin
diabeticandpossiblyprediabeticsubjects
-DiabeticagentsthatimprovecardiovascularriskIncidenceRatesofMIandMicrovascularEndpointsbyMeanSystolicBloodPressure:UKPDS110120130140150160170Incidenceper1000Person
Years(%)AdlerAIetal.BMJ2000;321:412-419.UpdatedMeanSystolicBloodPressure(mmHg)Adjustedforage,sex,andethnicgroupMyocardialInfarctionMicrovascularEndpointsIncidenceRatesofMIandMicrovascularEndpointsbyMeanHemoglobin
A1c:UKPDS567891011Incidenceper1000Person
Years(%)StrattonIMetal.BMJ2000;321:405-412.UpdatedMeanHemoglobinA1cConcentration(%)Adjustedforage,sex,andethnicgroupMyocardialInfarctionMicrovascularEndpointsPlasmaInsulinandTriglyceridesPredictIschemicHeartDisease:QuebecCardiovascularStudyDespresJPetal.NEnglJMed1996;334:952-957.OddsRatio<1212-15>15F-Insulin(U/ml)4.6p=0.005>150mg/dl<150mg/dlTriglycerides1.01.55.3p=0.001P<0.0016.75.4P=0.002PlasmaInsulinandApolipoproteinBPredictIschemicHeartDisease:QuebecCardiovascularStudyDespresJPetal.NEnglJMed1996;334:952-957.OddsRatio<1212-15>15F-Insulin(U/ml)3.0p=0.04>119mg/dl<119mg/dlApolipoproteinB1.01.53.2p<0.00111.09.7P<0.001p=0.04LDLParticleSizeandApolipoproteinBPredictIschemicHeartDisease:QuebecCardiovascularStudyLamarcheBetal.Circulation1997;95:69-75.>25.64<25.64LDLPeakParticleDiameter(nm)1.01.06.2(p<0.001)ApoB>120mg/dl2.0<120mg/dlBaselineAnthropometricVariablesandCardiovascularRiskFactorsinSubjectswithNormalGlucoseToleranceatBaselineAccordingtoConversionStatusat8-YearFollow-up:SanAntonioHeartStudyBMI(kg/m2)Centrality*TG(mmol)HDLC(mmol)SBP(mmHg)Fastingglucose(mmol)Fastinginsulin(pmol)HaffnerSMetal.JAMA1990;263:2893-2898.28.2+1.11.38+0.091.83+0.121.14+0.07116.8+3.05.28+0.1157+2727.2+0.21.16+0.21.26+0.101.28+0.02108.8+0.85.00+0.0281+5.472.472.006.045.004.032.006ConversionStatusatFollow-upDiabetes(n=18)Normal(n=490)P*Ratioofsubscapulartotricepsskinfolds“TickingClock〞HypothesisWHO.Diabetologia1985;28:615-640;HaffnerSMetal.JAMA1990;263:2893-2898.ForMicrovascularcomplicationsMacrovascularcomplicationsThe“clockstartsticking〞Atonsetofhyperglycemia
BeforethediagnosisofhyperglycemiaHemoglobinA1FastingGlucoseThe7-YearAge-AdjustedIncidenceofCHDMortalityandAllCHDEvents:East-WestStudyLehtoSetal.Diabetes1997;46:1354-1359.403020100%IncidenceP-glucose(mmol/L)<9.6>13.4403020100%IncidenceCHDMortalityAllCHDEventsCHDMortalityAllCHDEventsHbA1(%)<8.9>10.7StepwiseSelectionofRiskFactors*in2693WhitePatientswithType2DiabeteswithDependentVariableasTimetoFirstEvent:UKPDS
VariableLow-DensityLipoproteinCholesterolHigh-DensityLipoproteinCholesterolHemoglobinA1cSystolicBloodPressureSmokingPValue<0.00010.00010.00220.00650.056CoronaryArteryDisease(n=280)PositioninModelFirstSecondThirdFourthFifth*Adjustedforageandsex.TurnerRCetal.BMJ1998;316:823-828.CriteriaforAcceptingCardiovascularRiskFactorManagementasSimilarinDiabeticandCHDSubjectsTheriskofvasculardiseaseissimilarindiabeticsubjectswithoutpre-existingvasculardiseaseasinnondiabeticsubjectswithvasculardiseaseGlycemiaalonewillnotcompletelyeliminatetheexcessofCHDriskindiabeticsubjectsLipidinterventionstoreduceCHDcanbeequallyeffectiveindiabeticandnondiabeticsubjectsIncidenceofFatalorNonfatalMIDuringa7-YearFollow-upinRelationtoHistoryofMIinNondiabeticvsDiabeticSubjects:East-WestStudyIncidenceDuringFollow-up(%)(n=69)NondiabeticswithpriorMINondiabeticswithnopriorMIDiabeticswithpriorMIDiabeticswithnopriorMI18.8HaffnerSMetal.NEnglJ
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 电解质与非电解质
- 2024-2025学年高二上学期开学摸底考试 语文
- 智能化柜式或抽屉式断路器项目创业计划书
- 医生进修报告医生护士
- 柠檬汁项目创业计划书
- 台钻项目创业计划书
- 第八单元生命活动的调节与免疫
- 大学生毕业就业登记表自我鉴定
- 点滴网络教研系统操作手册
- 中班科学教案《恐龙 》
- 注塑生产日报表
- F燃机启动调试步骤【收藏资料】(2)
- 水上交通安全知识教学课件.ppt
- KET模拟测试(附答案)
- 2022年2022年餐饮公司企业文化
- 医务人员进修申请表
- 擦窗机施工方案
- 10以内加减练习题(田字格)直接打印
- 苏教版四年级数学上册第一单元《升和毫升》教材分析及全部教案(4个课时)
- 部编版四年级语文上册第五单元集体备课全部教案
- 人教部编版语文七年级上册生字词
评论
0/150
提交评论